Conceptio ›
Archive ›
Gestión del Repositorio Documental de la Universidad de Salamanca
Gestión del Repositorio Documental de la Universidad de Salamancametadata only
Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial
mieloma múltiple, aged, boronic acids, kaplan-meier estimate, risk assessment, humans, pyrazines, melphalan
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 296801
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.